Ellen Iacobaeus

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Journal: Neurology

Published: August 26, 2026

Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.

Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 03, 2025

Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.

Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: September 09, 2025

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Journal: Brain : a journal of neurology

Published: May 12, 2025

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.

Journal: Brain : a journal of neurology

Published: May 12, 2025

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus.

Journal: Journal of translational autoimmunity

Published: March 21, 2025

Correction: Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT.

Correction: Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT.

Journal: Bone marrow transplantation

Published: March 12, 2025

Impact of surgery in patients with multiple sclerosis: a nationwide cohort study.

Impact of surgery in patients with multiple sclerosis: a nationwide cohort study.

Journal: Frontiers in neurology

Published: February 08, 2025

Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 15, 2025

Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 15, 2025

Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT.

Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT.

Journal: Nature reviews. Neurology

Published: December 11, 2024

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.

De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.

Journal: Brain : a journal of neurology

Published: July 31, 2024

Showing 1-12 of 41

Last Updated: 09/26/2026